Hematology Oncology Associates of Central New York
- Research works
- 50 ▼ 4% vs 2013–17
- Citations
- 1.1k 22.0 per fractional work
- Top-10% rate
- 11.5% record average 16.5%
- Open access
- 26% world 28%
Not ranked overall: Hematology Oncology Associates of Central New York is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.5×. Every wedge is a field page.
Which keywords describe research at Hematology Oncology Associates of Central New York?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Quality of Life, Clinical Trials, Health-related Quality of Life, Radiotherapy, Prognostic Factors, Targeted Therapy and Epidemiology.
- Acute Pancreatitis
- Metastasis
- EGFR Mutations
- Treatment Guidelines
- Patient Satisfaction
- Genetic Factors
- Revision Surgery
- Patient-Reported Outcomes
- Breast Cancer
- Chemotherapy-Induced Peripheral Neuropathy
- Prophylaxis
- Feature Extraction
- Survival Analysis
- Metastatic Breast Cancer
- Clinical Practice Guidelines
- Cancer
- Targeted Therapy
- Radiotherapy
- Clinical Trials
- Quality of Life
- Chemotherapy
- Epidemiology
- Health-related Quality of Life
- Prognostic Factors
- Immunotherapy
- Precision Medicine
- Depression
- Risk Factors
- Anxiety
- Prevention
- Biomarkers
- Taxanes
- Cancer Survivorship
- Cancer Treatment
- Total Hip Replacement
- Genomic Profiling
- Rituximab
- ALK Inhibitors
- Medical Education
- Nutritional Support
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy5▲ 15×17 topics
- Quality of Life4▲ 6.7×12 topics
- Epidemiology4▲ 2.1×18 topics
- Clinical Trials3▲ 9.9×11 topics
- Health-related Quality of Life2▲ 24×4 topics
- Radiotherapy2▲ 13×6 topics
- Prognostic Factors2▲ 10×6 topics
- Targeted Therapy2▲ 21×3 topics
- Immunotherapy2▲ 6.3×9 topics
- Cancer2▲ 2.7×11 topics
- Precision Medicine2▲ 12×6 topics
- Clinical Practice Guidelines2▲ 6.5×7 topics
- Depression2▲ 4.7×4 topics
- Metastatic Breast Cancer2▲ 55×2 topics
- Risk Factors2▲ 3.3×4 topics
- Survival Analysis2▲ 13×5 topics
- Anxiety2▲ 8.8×3 topics
- Feature Extraction2▲ 12×2 topics
- Prevention2▲ 8.2×4 topics
- Prophylaxis2▲ 23×3 topics
- Biomarkers2▲ 4.7×7 topics
- Chemotherapy-Induced Peripheral Neuropathy2▲ 59×1 topic
- Taxanes2▲ 59×1 topic
- Breast Cancer1▲ 10×9 topics
- Cancer Survivorship1▲ 48×1 topic
- Patient-Reported Outcomes1▲ 76×1 topic
- Cancer Treatment1▲ 9.9×4 topics
- Revision Surgery1▲ 22×2 topics
- Total Hip Replacement1▲ 22×2 topics
- Genetic Factors1▲ 31×3 topics
- Genomic Profiling1▲ 25×2 topics
- Patient Satisfaction1▲ 9.5×3 topics
- Rituximab1▲ 15×2 topics
- Treatment Guidelines1▲ 12×3 topics
- ALK Inhibitors1▲ 39×1 topic
- EGFR Mutations1▲ 39×1 topic
- Medical Education1▲ 9.7×3 topics
- Metastasis1▲ 6.5×5 topics
- Nutritional Support1▲ 24×2 topics
- Acute Pancreatitis1▲ 43×1 topic
Which research topics does Hematology Oncology Associates of Central New York publish most on?
By volume in 2022–2025: Electronic Health Records Systems, Economic and Financial Impacts of Cancer, Lung Cancer Treatments and Mutations and Lung Cancer Research Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Electronic Health Records Systems Health Information Management 0 works
- 2 Economic and Financial Impacts of Cancer Economics and Econometrics 0 works
- 3 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
- 4 Lung Cancer Research Studies Oncology 0 works
- 5 Cancer Genomics and Diagnostics Cancer Research 0 works
- 6 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
- 7 Multiple Myeloma Research and Treatments Hematology 0 works
- 8 Acute Myeloid Leukemia Research Hematology 0 works
- 9 Nutrition, Genetics, and Disease Genetics 0 works
- 10 CAR-T cell therapy research Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Hematology Oncology Associates of Central New York's research output changed?
Output in 2018–2022 was 4% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in East Syracuse
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.